Neuronal expression of the ubiquitin ligase Nedd4-2 in rat dorsal root ganglia: modulation in the SNI model of neuropathic pain by Cachemaille, M.
 
 
Unicentre 
CH-1015 Lausanne 
http://serval.unil.ch 
 
 
 
Year : 2013 
 
Neuronal expression of the ubiquitin ligase Nedd4-2 in 
rat dorsal root ganglia: modulation in the SNI model of 
neuropathic pain 
 
 
Matthieu Alexandre Cachemaille 
 
 
 
 
Matthieu Alexandre Cachemaille, 2013, Neuronal expression of the ubiquitin ligase 
Nedd4-2 in rat dorsal root ganglia: modulation in the SNI model of neuropathic pain 
 
 
Originally published at : Thesis, University of Lausanne 
 
Posted at the University of Lausanne Open Archive. 
http://serval.unil.ch 
 
 
Droits d’auteur 
L'Université de Lausanne attire expressément l'attention des utilisateurs sur le fait que tous les 
documents publiés dans l'Archive SERVAL sont protégés par le droit d'auteur, conformément à la 
loi fédérale sur le droit d'auteur et les droits voisins (LDA). A ce titre, il est indispensable d'obtenir 
le consentement préalable de l'auteur et/ou de l’éditeur avant toute utilisation d'une oeuvre ou 
d'une partie d'une oeuvre ne relevant pas d'une utilisation à des fins personnelles au sens de la 
LDA (art. 19, al. 1 lettre a). A défaut, tout contrevenant s'expose aux sanctions prévues par cette 
loi. Nous déclinons toute responsabilité en la matière. 
 
Copyright 
The University of Lausanne expressly draws the attention of users to the fact that all documents 
published in the SERVAL Archive are protected by copyright in accordance with federal law on 
copyright and similar rights (LDA). Accordingly it is indispensable to obtain prior consent from the 
author and/or publisher before any use of a work or part of a work for purposes other than 
personal use within the meaning of LDA (art. 19, para. 1 letter a). Failure to do so will expose 
offenders to the sanctions laid down by this law. We accept no liability in this respect. 
  
UNIVERSITE DE LAUSANNE - FACULTE DE BIOLOGIE ET DE MEDECINE 
 
Département des services de chirurgie et d'anesthésiologie  
  
Service d'anesthésiologie 
 
 
 
 
 
Neuronal expression of the ubiquitin ligase Nedd4-2 in rat dorsal root 
ganglia: modulation in the SNI model of neuropathic pain 
 
 
THESE 
 
 
préparée sous la direction du Professeur associé Isabelle Décosterd 
      
      
 
et présentée à la Faculté de biologie et de médecine de 
l’Université de Lausanne pour l’obtention du grade de 
 
 
 
DOCTEUR EN MEDECINE 
 
 
par 
 
 
Matthieu Alexandre Cachemaille 
 
 
Médecin diplômé de la Confédération Suisse  
Originaire de Baulmes, Vaud 
 
 
 
Lausanne 
 
2012 

  
    
 
 
Rapport de synthèse 
 
 
La douleur neuropathique est une forme de douleur chronique apparaissant suite à des lésions 
du système nerveux somato-sensoriel. Caractérisée par une plasticité neuronale inadaptée, elle 
est très souvent intense, invalidante, associe des symptômes comme l’allodynie ou 
l’hyperalgésie et reste difficile à traiter avec les agents thérapeutiques actuels.   
Le thème de mon travail de thèse se concentre sur des mécanismes moléculaires de 
modulation des canaux sodiques voltage-dépendants suite à une lésion du nerf périphérique.  
Dans l’article présenté en annexe, j’ai focalisé mon travail sur une protéine, Nedd4-2, qui est 
une ligase ubiquitine. Elle a pour rôle de réguler et d’internaliser dans la cellule des protéines 
membranaires dont les canaux sodiques. Suite aux lésions du système nerveux périphérique, il 
existe une hyperexcitabilité neuronale engendrée notamment par un surplus et une 
dysrégulation des canaux sodiques à la membrane cellulaire. Dans l’hypothèse que 
l’ubiquitine ligase Nedd4-2 soit présente dans les neurones sensitifs primaires et ait un rôle 
dans la régulation des canaux sodiques, nous avons identifié cette protéine dans les neurones 
nociceptifs primaires du rat. En utilisant des techniques de Western Blot et 
d’immunohistochimie, j’ai trouvé que Nedd4-2 est présente dans presque 50% des neurones 
du ganglion spinal et ces neurones sont principalement des neurones nociceptifs. Dans un 
modèle expérimental de douleur neuropathique (SNI, pour spared nerve injury), Nedd4-2 se 
retrouve significativement diminuée dans le tissu du ganglion spinal. J’ai également 
investigué l’expression de 2 isoformes des canaux sodiques connues pour leur implication 
dans la douleur, Nav1.7 et Nav1.8, et ces 2 isoformes se retrouvent dans les mêmes neurones 
que Nedd4-2. La caractérisation détaillée est décrite dans le manuscrit:  
« Neuronal expression of the ubiquitin ligase Nedd4-2 in rat dorsal root ganglia: modulation 
in the SNI model of neuropathic pain; Cachemaille M, Laedermann CJ, Pertin M, Abriel H, 
Gosselin RD, Decosterd I. » 
Les résultats obtenus indiquent que Nedd4-2, en étant downrégulé après une lésion nerveuse, 
pourrait ainsi contribuer à une augmentation des canaux sodiques fonctionnels à la membrane. 
Ainsi Nedd4-2 pourrait être proposée comme cible thérapeutique de manière alternative aux 
bloqueurs de canaux sodiques.  
Ce travail a permis l’initiation d’autres expériences. J’ai contribué activement à la 
construction de vecteurs viraux type adéno-associé recombinant (rAAV2/6) et surexprimé la 
protéine in vivo dans les ganglions spinaux. Cette partie de mon travail se trouve intégrée 
dans d’autres travaux de mon laboratoire d’accueil qui a pu démontrer les effets fonctionnels 
de cette approche sur les courants sodiques enregistrés par électrophysiologie et une 
diminution de la douleur neuropathique chez la souris. 
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cDepartment of Clinical Research, University of Bern, Bern,
SwitzerlandAbstract—Neuronal hyperexcitability following peripheral
nerve lesions may stem from altered activity of voltage-
gated sodium channels (VGSCs), which gives rise to
allodynia or hyperalgesia. In vitro, the ubiquitin ligase
Nedd4-2 is a negative regulator of VGSC a-subunits (Nav),
in particular Nav1.7, a key actor in nociceptor excitability.
We therefore studied Nedd4-2 in rat nociceptors, its
co-expression with Nav1.7 and Nav1.8, and its regulation in
pathology. Adult rats were submitted to the spared nerve
injury (SNI) model of neuropathic pain or injected with com-
plete Freund’s adjuvant (CFA), a model of inﬂammatory
pain. L4 dorsal root ganglia (DRG) were analyzed in sham-
operated animals, seven days after SNI and 48 h after CFA
with immunoﬂuorescence and Western blot. We observed
Nedd4-2 expression in almost 50% of DRG neurons, mostly
small and medium-sized. A preponderant localization is
found in the non-peptidergic sub-population. Additionally,
55.7 ± 2.7% and 55.0 ± 3.6% of Nedd4-2-positive cells are
co-labeled with Nav1.7 and Nav1.8 respectively. SNI
signiﬁcantly decreases the proportion of Nedd4-2-positive
neurons from 45.9 ± 1.9% to 33.5 ± 0.7% (p< 0.01) and
the total Nedd4-2 protein to 44%± 0.13% of its basal level
(p< 0.01, n= 4 animals in each group, mean ± SEM). In
contrast, no change in Nedd4-2 was found after peripheral
inﬂammation induced by CFA. These results indicate that
Nedd4-2 is present in nociceptive neurons, is downregu-
lated after peripheral nerve injury, and might therefore0306-4522/12 $36.00  2012 IBRO. Published by Elsevier Ltd. All rights reserve
http://dx.doi.org/10.1016/j.neuroscience.2012.09.044
*Correspondence to: M. Cachemaille, Pain Center, Department of
Anesthesiology, University Hospital Center (CHUV) and University
of Lausanne (UNIL), Bugnon 46, 1011 Lausanne, Switzerland.
Tel: +41-21-314-11-11; fax: +41-21-314-20-04.
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Abbreviations: ATF-3, Activating Transcription Factor 3; CFA,
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Embryonic Kidney cells; IB4, isolectin B4; IR, immunoreactivity; NGS,
normal goat serum; RT, room temperature; SNI, spared nerve injury;
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1contribute to the dysregulation of Navs involved in the
hyperexcitability associated with peripheral nerve injuries.
 2012 IBRO. Published by Elsevier Ltd. All rights reserved.
Key words: Nedd4-2, neuropathic pain, voltage-gated sodium
channels, Nav1.7, Nav1.8, dorsal root ganglion.
INTRODUCTION
Neuropathic pain aﬀects a high proportion of the world
population (Bouhassira et al., 2008) and originates from
a maladaptive plasticity caused by a lesion in the
somatosensory system (Woolf and Salter, 2000;
Costigan et al., 2009). Clinically, it is associated
with sensory dysfunctions referred as spontaneous pain,
allodynia and hyperalgesia (Woolf and Decosterd,
1999). Convergent studies have shown that after a
peripheral nerve lesion, ectopic activity, potentially
accounting for pain symptoms, arises in injured and
non-injured Ab (normally non-nociceptive), Ad and
C-ﬁbers (nociceptive) and in dorsal root ganglion (DRG)
(Ma et al., 2003; Wu et al., 2001; Devor, 2009).
Membrane hyperexcitability is thought to cause such
abnormal generation of action potentials in DRG
neurons (Amir et al., 2005) with the dysregulation of
voltage-gated sodium channels (VGSCs) being the
cornerstone of this regulation (Rush et al., 2007; Sheets
et al., 2008).
Increased membrane ion permeability during action
potential relies on the pore forming a-subunit (Nav) of
VGSCs, and its inhibition explains conduction blockade
by local anesthetics (Catterall, 2000). Remarkably, the
stability and internalization of ion channels are under the
control of post-translational modiﬁcations, especially
their ubiquitylation by E3 ubiquitin ligases driving their
routing to degradation (Abriel and Staub, 2005). In
particular the Nedd4 family of E3 proteins are potent
regulators of channels, including Nav (Abriel et al., 1999;
Harvey and Kumar, 1999; van Bemmelen et al., 2004;
Kabra et al., 2008). Most of the ten Nav isoforms are
expressed in DRG neurons and contribute to
electrogenesis, with a speciﬁc expression for Nav1.7,
Nav1.8 and Nav1.9 in the peripheral nervous system
(Black et al., 2002; Rush et al., 2007; Ho and O’Leary,
2011). Interestingly, mutations leading to loss or gain of
Nav1.7 function result in congenital insensitivity to pain
or lead to severe familial pain disorders (Raouf et al.,
2010). Mice with selective knock out of Nav1.7, Nav1.8d.
2 M. Cachemaille et al. / Neuroscience xxx (2012) xxx–xxxand Nav1.9 in DRG neurons have reduced pain
sensitivity or diminished response to inﬂammatory pain
(Nassar et al., 2004). These data suggest a key role of
peripheral Navs in basal nociception, and also a
possible impact of the regulation of nociceptor-speciﬁc
Nav in pathological pain. Various reports have indicated
that inﬂammatory and neuropathic pain are associated
with changes in Nav1.7, Nav1.8 and Nav1.9 expression
at both the mRNA and the protein levels in DRG
neurons (Cummins and Waxman, 1997; Berta et al.,
2008; Strickland et al., 2008; Thakor et al., 2009) but
the mechanism leading to the selective alteration of
some Nav currents in neuropathic pain is still unclear
(Berta et al., 2008). One theory posits the existence of
reﬁned mechanisms at the post-translational level
leading to change in Nav function or traﬃcking. In this
context Nedd4-2, a well-described Nedd4 member, can
interact with all Navs expressed in DRG neurons (except
Nav1.9) via their C-terminal PY motive. Indeed, Xenopus
oocytes exogenously coexpressing Nedd4-2 with
Nav1.2, 1.7 and 1.8 present a reduction of their
respective currents (Fotia et al., 2004). However,
despite the apparent importance of Nav regulation by
Nedd4-2, the expression of Nedd4-2 in the nociceptive
pathway has not been studied so far.
The aim of the present study is ﬁrst to investigate
in vivo the expression of Nedd4-2 in rat DRG and
characterize its localization in the diﬀerent subpo-
pulations of primary sensory neurons using speciﬁc
markers. In addition, we have assessed Nedd4-2
modulation in rodent models of neuropathic and
inﬂammatory pain. Our results indicate that Nedd4-2
immunoreactivity (IR) is present in small diameter
nociceptive neurons together with Nav1.7 and Nav1.8
and that this expression is down-regulated after nerve
injury.EXPERIMENTAL PROCEDURES
Surgery
All procedures were approved by the Committee on Animal
Experimentation for the Canton of Vaud, Switzerland, in
accordance with Swiss Federal Law on Animal Welfare and
guidelines of the International Association for Study of Pain
(IASP) (Zimmermann, 1983). We used the spared nerve
injury (SNI) model of neuropathic pain as previously described
(Decosterd and Woolf, 2000). Brieﬂy, adult Sprague–Dawley
rats were deeply anesthetized using 1.5% isoﬂurane and,
after exposure of the sciatic nerve, the common peroneal and
tibial nerves were ligated with 5.0 silk sutures and transected
while the sural nerve was left intact. Muscle and skin were
closed in two distinct layers with 5.0 silk thread and wound
clips. Sham surgery was performed similarly, although without
nerve damage, as the control condition. Eight animals were
used for SNI (n= 4 for immunolabeling and n= 4 for
Western blot) and a similar group of eight rats was used for
sham surgery.
For experiments with complete Freund’s adjuvant (CFA), rats
were injected with 50 ll of CFA (Sigma, St. Louis MO, USA,
n= 4) or NaCl 0.9% (n= 4), in the dorsal part of the left
hindpaw, under isoﬂurane anesthesia (1.5% isoﬂurane).
Animals were kept for 48 h and tissues dissected at this time-
point for further analysis (Nagakura et al., 2003).Please cite this article in press as: Cachemaille M et al. Neuronal expression of
spared nerve injury model of neuropathic pain. Neuroscience (2012), http://dx.Immunohistochemistry
One week after the SNI surgery or 48 h after CFA injection,
animals were lethally anesthetized with sodium pentobarbital
and transcardially perfused with saline, followed by
paraformaldehyde 4% in PBS. L4 DRGs (Hammond et al.,
2004) were dissected and post-ﬁxed at 4 C for 90 min and
then transferred in 20% sucrose in PBS overnight. The
following day, tissues were mounted in cryoembedding ﬂuid
(Tissue-Tek; Sakura Finetek, Zoeterwoude, Holland). Then
samples were frozen, cryosectioned in 12-lm thick sections
and thaw-mounted onto slides.
Nedd4-2 was revealed using a speciﬁc rabbit anti-Nedd4-2
antibody (Nedd4-2, 1:100, generously provided by Olivier
Staub, Department of Pharmacology and Toxicology, University
of Lausanne, Switzerland). For the colocalization experiments,
antibodies were as follows: mouse anti-peripherin (Peripherin;
1:500, Chemicon International, Billerica, MA, USA), mouse
anti-neuroﬁlament 200 (NF200, 1:400, Sigma, St. Louis, MO,
USA), rat anti-Substance P (1:400, BD Bioscience, Basel,
Switzerland), mouse anti-Nav1.7 (1:100, Neuromab, Davis, CA,
USA), mouse anti-Nav1.8 (1:100, Neuromab, Davis, CA, USA),
rabbit anti-Activating Transcription Factor 3 (ATF-3, 1:200,
Santa Cruz Biotechnology, Heidelberg, Germany). Secondary
antibodies were as follows: Cy3-conjugated anti-rabbit (1:400,
Jackson ImmunoResearch, Suﬀol, UK) for Nedd4-2,
Cy3-conjugated anti-mouse (1:300, Jackson ImmunoResearch)
for Nav1.7, FITC-conjugated anti-rabbit (1:200, Jackson
ImmunoResearch, Suﬀol) for ATF-3, FITC-conjugated anti-rat
(1:200, Jackson ImmunoResearch, Suﬀol) for Substance P,
Alexa 488 anti-rabbit (1:500, Molecular Probes, Basel,
Switzerland) for Nedd4-2 and Alexa 488 anti-mouse (1:1000,
Molecular Probes) for peripherin, NF200, Nav1.8. Non-
peptidergic neurons were stained using biotinylated griﬀonia
simplicifolia Isolectin B4 (IB4) (1:100, Vector Laboratories,
Burlingame, CA) followed by AMCA-conjugated streptavidin
(1:50; Jackson ImmunoResearch). Standard protocols for
ﬂuorescent immunohistochemistry were used. Sections of
DRGs were blocked for 30 min at room temperature (RT) with
10% normal goat serum (NGS) and 0.3% PBS 1X-Triton
X-100. Primary antibodies were diluted in 5% NGS and 0.1%
PBS 1X-Triton X-100, and incubated on sections overnight at
4 C. For ATF-3/Nedd4-2 dual labeling, the sequence of the
protocol started with the primary and secondary incubations for
ATF-3 followed by primary and secondary probing for Nedd4-2
(Pertin et al., 2005; Fukuoka et al., 2012). Control experiments
were performed to rule out the possibility of a nuclear presence
of Nedd4-2. Slides were washed in PBS and then incubated at
RT with the corresponding secondary antibody or AMCA-
conjugated streptavidin diluted in NGS 1% and PBS 1X-Triton
X-100 0.1% for 90 min. Slides were washed in PBS and
mounted in Mowiol medium (Calbiochem, Gibbstown, NJ).Pictures and counting
Fluorescence was detected using an epiﬂuorescent microscope
(AxioPlan and AxiVision, Carl Zeiss, Feldbach, Switzerland).
Images were taken at 20 magniﬁcation, with the same
parameters used between experimental conditions, saved as
TIFF ﬁles and then juxtaposed as one picture using Photoshop
CS4 software (11.0, Sun Microsystems, Redwood City, CA) in
order to reconstruct a complete DRG. The same parameters
for image capture were used between experimental conditions
and ganglia from four animals were analyzed per condition.
Mean cell counts from each animal were the average of four
sections selected 60 lm apart. The ﬁrst slide was randomly
selected and the three next ones were chosen every ﬁve slides
from the series of consecutive cut sections. In all conditions,
only neurons in which the nucleus was visible were counted.
The observer was blinded to experimental groups. Counts ofthe ubiquitin ligase Nedd4-2 in rat dorsal root ganglia: Modulation in the
doi.org/10.1016/j.neuroscience.2012.09.044
M. Cachemaille et al. / Neuroscience xxx (2012) xxx–xxx 3labeled neuronal proﬁles were expressed as a percentage of the
total number of labeled and unlabeled neuronal proﬁles. Neuronal
cross-sectional areas were measured in lm2 and the mean gray
value of each cell was recorded based on mean pixel intensity
using ImageJ software (1.42, National Institute of Mental
Health, Bethesda, MD, USA). Groups for cell area were as
follows: 0–600 lm2 for small neurons, 600–1200 lm2 for
medium-sized neurons and >1200 lm2 for large neurons
(Harper and Lawson, 1985; Noguchi et al., 1993).Threshold of detection for IR-positive cells
Positively labeled cells were identiﬁed on acquired digital images
by the experimenter. The accuracy of detection was veriﬁed for
each condition by determining the signal/background threshold
as follows (King et al., 2009). Ten pictures were randomly
chosen in images libraries of four independent markers
(Nedd4-2, Nav1.7, peripherin and NF-200). Background
intensities were measured and averaged. The ﬁnal threshold of
mean gray values was calculated by adding two standard
deviations, giving a value of 18. Twenty out of 718 Nedd4-2-
positive cells (sham) and 42 out of 616 positive cells (SNI)
were below the detection threshold. For Nav1.7 counting, all
positive cells were above the detection threshold.ACell transfection
Human Embryonic Kidney cells (HEK293) were cultured in
DMEM (Gibco, Life Technologies, Zug, Switzerland)
supplemented with 10% fetal bovine serum, 0.2% glutamine
and gentamicin (20 mg/mL) at 37 C in a 5% CO2 incubator.
For control of antibodies, cells were transfected, using calcium
phosphate, with 0.8 lg of truncated human Nedd4-2 cDNA
(without the amino-terminal C2 domain) cloned into pcDNA3.1
(generously provided by Olivier Staub, Department of
Pharmacology and Toxicology, Lausanne, Switzerland) or 1 lg
of Nav1.7 cDNA cloned into pCIN5h and provided by Dr. Simon
Tate (Convergence Pharmaceuticals, Cambridge, UK). Protein
extraction was performed 48 h after transfection.B
GAPDH
Nedd4-2
150
130
100
75
kDa
34
1 2 3
Nedd4-2
Fig. 1. Protein expression of Nedd4-2 in rat DRG. (A) Nedd4-2-
immunoreactivity (IR) in rat L4 DRG (scale bar = 100 lm). (B)
Western blot analysis of Nedd4-2. Lane 1: rat L4 DRG; lane 2:
HEK293 cells; lane 3: Nedd4-2 transfected HEK293 cells; GAPDH
was used as a loading control.Western blotting
Animals were sacriﬁced 7 days after Sham or SNI surgery, or
48 h after CFA injection. L4 and L5 DRGs were quickly
dissected and kept at 80 C until use. HEK293 transfected
cells were detached using dissociation buﬀer (Invitrogen, Life
Technologies), centrifuged at 2000g for 2 min at RT and
supernatants were removed. Homogenization of DRGs or HEK
cells was done in 100 mM Tris–HCl (pH 6.8), SDS 2%, glycerol
20%, NaCl and complete protease inhibitor cocktail tablets
(Roche, Basel, Switzerland). Samples were centrifuged at
14,000 rpm for 20 min at 4 C and proteins in the supernatants
were quantiﬁed using Bradford assays. Protein samples
(15–20 lg) were separated by SDS–PAGE and transferred
onto PVDF membranes (BioRad, Hercules, CA). Blots were
blocked with non fat dry milk 5% for 30 min at RT and then
incubated overnight at 4 C with the appropriate antibody:
rabbit anti-Nedd4-2 (1:100) (Flores et al., 2005), mouse anti-
Nav1.7 (1:400, Neuromab) or mouse anti-Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH, 1:500,000, Abcam,
Cambridge, UK). These blots were further incubated with
horseradish peroxydase-conjugated secondary antibody anti-
mouse or anti-rabbit (1:2000, Dako, Heverlee, Belgium),
developed in Super Signal Solution (Pierce, Rockford, IL, USA)
and revealed with LAS-4000-Mini Fujiﬁlm (Bucher Biotec,
Basel, Switzerland). Pixel intensities were quantiﬁed with
ImageJ. Results were expressed as the ratio of the signal of
interest over sham after normalization by GAPDH loading control.Please cite this article in press as: Cachemaille M et al. Neuronal expression of
spared nerve injury model of neuropathic pain. Neuroscience (2012), http://dx.Statistics
Data are represented as mean ± SEM. Comparisons between
groups were performed using Student’s t test or a one-way
ANOVA followed by Dunnett’s Multiple Comparison Test for
Fig. 3F. Statistical analyses were done with JMP statistical
software (5.01, SAS institute, Cary, NC). Diﬀerences were
considered signiﬁcant at p-values below 0.05.RESULTS
Nedd4-2 is present in nociceptive neurons
Nedd4-2 IR is widely distributed in rat DRG neurons
(Fig. 1A). Western blot analysis (Fig. 1B) reveals one
major band in DRG at approximately 120 kDa corres-
ponding to the endogenous form of Nedd4-2 (lane 1). In
HEK293 cells, the endogenous form of Nedd4-2
corresponds to a slightly lower band (115 kDa), in line
with species diﬀerences (van Bemmelen et al., 2004;
Rougier et al., 2005). In DRG, we inconstantly observed
one additional band between 100 and 120 kDa, which is
known to be a splice variant (Itani et al., 2003; Hryciw
et al., 2004) (see Figs. 3A and 5B). As a positive
control, the analysis of HEK293 cells transfected with a
truncated form of human Nedd4-2 cDNA showed a
robust protein level at 100 kDa, in line with the size of
the construct (Kamynina et al., 2001).
We thoroughly explored the molecular identity of
Nedd4-2-immunopositive DRG neurons using dual
immunoﬂuorescence (Fig. 2). The six sets of counting
performed throughout our study gave overall
percentages of Nedd4-2-expressing neurons rangingthe ubiquitin ligase Nedd4-2 in rat dorsal root ganglia: Modulation in the
doi.org/10.1016/j.neuroscience.2012.09.044
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Fig. 2. Nedd4-2 is mainly present in nociceptive DRG neurons and colocalizes with the sodium channels Nav1.7 and Nav1.8. (A) Representative
double immunoﬂuorescence for Nedd4-2 (ﬁrst column) with the markers peripherin, NF-200, IB4, Substance P, or with Nav1.7 and Nav1.8 (second
column) and merged images (third column, arrows) in rat DRG neurons (sham group). (B) Quantitative analysis of Nedd4-2-IR with the diﬀerent
markers. Among all Nedd4.-2-positive neurons, 54.8 ± 3.8% co-stained for peripherin, 7.8 ± 2.7% for NF-200, 51.9 ± 2.2% for IB4, 9.0 ± 1.2%
for Substance P, 57.7 ± 2.7% for Nav1.7 and 55.0 ± 3.6% for Nav1.8. (C) Among the following markers, many co-stained with Nedd4-2: peripherin
(65.6 ± 3.2%), NF-200 (13.1 ± 3.7%), IB4 (77.3 ± 4.6%), Substance P (33.1 ± 2.8%), Nav1.7 (64.0 ± 2.9%) and Nav1.8 (59.4 ± 4.9%). Data are
presented as mean ± SEM. n= 4. Scale bar = 50 lm.
4 M. Cachemaille et al. / Neuroscience xxx (2012) xxx–xxxfrom 43.3 ± 2.6% to 49.6 ± 0.9% of total neurons
(n= 4). Peripherin, an intermediate ﬁlament selective
for small sensory neurons presumably nociceptive, is
found in about half of neurons with Nedd4-2-IR (Fig. 2B)Please cite this article in press as: Cachemaille M et al. Neuronal expression of
spared nerve injury model of neuropathic pain. Neuroscience (2012), http://dx.and conversely Nedd4-2-IR is present in a large majority
of peripherin-positive neurons (Fig. 2C). Nedd4.2 is
weakly expressed in the NF200-postive large myeli-
nated ﬁber cell population. Within the subpopulations ofthe ubiquitin ligase Nedd4-2 in rat dorsal root ganglia: Modulation in the
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expressed in DRG neurons and is predominantly
localized in small diameter sensory neurons, which
include many nociceptive neurons.Nedd4-2-IR is decreased after SNI
In order to test the hypothesis that Nedd4-2 plays a role in
the hyperexcitability associated with neuropathic pain in
rats, we explored the regulation of its expression
following peripheral nerve injury. Using Western blot
analysis of L4 DRG (Fig. 3A and B), we observed a
decrease of about 56% in Nedd4-2 protein content
after SNI. Similar results were observed using
immunoﬂuorescence on DRG (Fig. 3E and F):
quantiﬁcation indicated a decrease in the number of
Nedd4-2-IR cell proﬁles after SNI. In addition, we
evaluated whether Nedd4-2 signal could be shifted to
another DRG neurons subpopulation after nerve injury
(Fig. 3C). The distribution of Nedd4-2-positive neurons
in DRG cells of diﬀerent sizes conﬁrms an expression
mainly in small neurons (<600 lm2), but no signiﬁcant
diﬀerence was detected between sham and SNI groups.
The reduction of Nedd4-2-IR observed after SNI is not
associated with a decrease of mean pixel intensity
calculated for individual neurons (Fig. 3D), but rather
with a reduced number of Nedd4-2-expressing neurons
(Fig. 3F).Please cite this article in press as: Cachemaille M et al. Neuronal expression of
spared nerve injury model of neuropathic pain. Neuroscience (2012), http://dx.We therefore investigated whether the downregulation
of Nedd4-2-IR occurs in injured DRG neurons (injured
aﬀerents of the tibial and peroneal nerves) after SNI,
which are known to be positive for the transcription
factor ATF-3 (Tsujino et al., 2000; Miyoshi et al., 2011).
As anticipated, the proportion of immunoreactive
neurons for ATF-3 in SNI rats is higher than in the sham
group (34.8 ± 2.8% as compared to 4.8 ± 0.2%), yet a
detailed analysis shows that downregulation of Nedd4-2
occurs in both injured (ATF positive) and the remaining
non-injured (ATF negative) neurons present in the DRG
(Fig. 3F). This suggests that neuronal deterioration and
in turn the previously reported neuronal death following
nerve section (Tandrup et al., 2000; McKay Hart et al.,
2002) is unlikely to account for the reduction of Nedd4-2
IR, in line with the reported absence of neuronal death
in neuropathic pain without axonal injury (Schaeﬀer
et al., 2010).Nedd4-2-IR colocalizes with sodium channels Nav1.7
and Nav1.8
The regulation of ion channels by Nedd4-2, in particular
the voltage-gated sodium channels Nav1.7 and Nav1.8,
implies their coexpression in the same DRG neurons. In
line with this hypothesis, strong colocalizations between
Nedd4-2 and Nav1.7 (Figs. 2 and 4A) or Nav1.8 (Fig. 2)
were found. More than 60% of Nav1.7-positive neuronsthe ubiquitin ligase Nedd4-2 in rat dorsal root ganglia: Modulation in the
doi.org/10.1016/j.neuroscience.2012.09.044
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concomitantly with Nedd4-2 downregulation after SNI
(64.0 ± 2.9% to 40.1 ± 3.0% in sham and SNI groups
respectively, p< 0.01, n= 4 in each group).
A signiﬁcant increase in the number of Nav1.7
immunoreactive neuronal proﬁles is observed after SNI
as compared to sham (Fig. 4B), without any signiﬁcant
change in the distribution of Nav1.7-IR cross-sectional
area (Fig. 4C). The enrichment in Nav1.7-IR is mostly
observed in small neurons (0–600 lm2) and a
simultaneous increase in mean pixel intensity is
observed in individual cells of this category after SNI
(Fig. 4D). Remarkably, Western blot quantiﬁcation
shows a decrease in Nav1.7 content in DRG after SNI
(Fig. 4F–G).
Many Nav1.8-IR cells express Nedd4-2 (Fig. 2A–C) in
a proportion that is not altered by SNI (59.4 ± 4.9% and
59.6 ± 5.3% in sham and SNI groups respectively,
n= 4). Conversely, 55.0 ± 3.6% of Nedd4-2-IR proﬁles
showed Nav1.8-IR, but this proportion was signiﬁcantly
decreased to 38.6 ± 4.4% after SNI (p< 0.05, n= 4).
This parallels the known downregulation of Nav1.8 after
peripheral nerve injury, which is here conﬁrmed by the
decrease of cells expressing Nav1.8 in DRG:
46.9 ± 5.2% of total DRG neuronal proﬁles showed
Nav1.8-IR from control rats compared with 21.1 ± 1.7%
of DRG neuronal proﬁles from SNI animals (p< 0.01,
n= 4).
Nedd4-2 IR is not altered by peripheral inﬂammation
We further tested the hypothesis that Nedd4-2 might be
regulated after peripheral inﬂammation (Fig. 5). As
shown in (Fig. 5A and B) 48 h following intraplantar
injection of CFA, neither the density of Nedd4-2-positive
neurons nor the global Nedd4-2 content was modiﬁed.
DISCUSSION
In the present study, we characterized the expression of
Nedd4-2 in primary sensory neurons and showed its
downregulation after a peripheral nerve lesion. Using
immunoﬂuorescence and Western blot, we ﬁrst
established the presence of Nedd4-2-IR in DRG
neurons and its main localization in small-diameter
neurons. Furthermore, after SNI, we found a signiﬁcant
decrease in Nedd4-2 content in DRG neurons. Finally
we demonstrated that the expressions of Nav1.7 and
Nav1.8 strongly co-localize with Nedd4-2-IR in the basal
condition and after peripheral nerve injury.
The demonstration of a colocalization between
Nedd4-2 and Nav1.7 or Nav1.8 immunoreactivities was
the ﬁrst crucial step before postulating an involvement of
Nedd4-2 in the regulation of Nav after peripheral nerve
injury. In rat DRG, we found that a large proportion of
neurons were immunoreactive for Nedd4-2, a proportion
that further increased when we considered the sole
population of small neurons that express peripherin. This
result, together with the low percentage of Nedd4-2-
positive cells in myelinated NF200 immunoreactive
neurons (presumably non-nociceptive except the Ad sub-
population), suggests that Nedd4-2 may have a role toPlease cite this article in press as: Cachemaille M et al. Neuronal expression of
spared nerve injury model of neuropathic pain. Neuroscience (2012), http://dx.play in the physiology of nociceptive neurons. In
addition, the further enrichment of Nedd4-2 in
IB4-positive nociceptive neurons (77.3 ± 4.6%) indi-
cates a putative speciﬁc role of Nedd4-2 in the
excitability of non-peptidergic nociceptors, a cell popu-
lation described as having longer duration action
potentials and expressing a high density of Nav1.8
(Stucky and Lewin, 1999). The marked downregulation
of Nedd4-2-IR in DRG neurons following peripheral
nerve injury suggests changes in ion channel traﬃcking
and the possible role of this in neuropathic pain is a
promising subject for future study. After nerve injury, the
reduced proportions of Nedd4-2-positive neurons were
not signiﬁcantly diﬀerent between injured (ATF-3
positive) and non-injured (ATF-3 negative) DRG
neuronal populations. This might imply that Nedd4-2
downregulation contributes to Nav turnover in both
injured (axotomized) and non-injured adjacent neurons.
Sodium channels exist both at the plasma membrane
and in intracellular pools (Schmidt et al., 1985; Ritchie
et al., 1990). Multiple and complex mechanisms
contribute to the forward traﬃcking of sodium channels
– and other voltage-gated ion channels – from the
intracellular pool to their subsequent functional insertion
in the plasma membrane. In this process, insertion is
counter-balanced by various post-translational
modiﬁcations including ubiquitylation and consequent
internalization of the channel (Jenkins and Bennett,
2001; Okuse et al., 2002; Garrido et al., 2003; Mohler
et al., 2004; Lopez-Santiago et al., 2006), a pheno-
menon in which Nedd4-2 has been implicated in trans-
fected cells (Fotia et al., 2004). In SNI, the Nedd4-2
decrease may inﬂuence this balance, possibly leading to
an accumulation of Nav at the cell membrane while the
total quantity of sodium channels in neurons may
remain stable. This mechanism might explain
discrepancies that have been reported between the
apparent rate of Nav synthesis and the observed
functional current, as in the case of TTX sensitive Nav
isoforms (Berta et al., 2008). In accordance with
previous studies on Nav1.7 transcriptional expression
(Raymond et al., 2004; Berta et al., 2008), we found a
signiﬁcant reduction in total Nav1.7 protein after SNI.
Nevertheless, the number of Nav1.7-IR neurons was
increased after SNI. This discrepancy might originate
from a redistribution of Nav1.7 protein to a diﬀerent
neuronal compartment more easily accessible to the
antibody, such as plasma membrane. It is also possible
that following peripheral nerve injury Nav1.7 is
upregulated but redistributed from the soma of sensory
neurons toward ﬁbers resulting in apparent
simultaneous signal reduction in the cell bodies and
increase in the total DRG protein content.
Further investigations should be conducted in order to
distinguish the membrane and intracellular pools of
Nav1.7 using electrophysiological and biochemical appro-
aches. Nav1.7 has so far never been investigated in DRG
using patch clamp techniques due to the diﬃculty to
selectively isolate its currents. Interestingly, however,
Nav1.7 speciﬁc blockers have recently been developed
and will allow Nav1.7 exploration (Schmalhofer et al.,the ubiquitin ligase Nedd4-2 in rat dorsal root ganglia: Modulation in the
doi.org/10.1016/j.neuroscience.2012.09.044
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strategies might also be employed to quantify the
internalization and membrane targeting of Nav in
neuropathic pain and the importance of the speciﬁc
interaction with Nedd4-2 in this process.
The strong downregulation of Nav1.8, in line with
many other studies but in apparent contradiction of our
hypothesis, would suggest that a transcriptional
downregulatory mechanism predominates regardless of
the inhibition by Nedd4-2 of channel internalization.
In addition, it was already proposed that the
downregulation of Nav1.8 mRNA and protein in DRGs is
due to a redistribution of this channel along the axons of
injured (Thakor et al., 2009) or uninjured nerves (Gold
et al., 2003). Nedd4-2 downregulation in the DRG might
also impact Nav1.8 expression at the membrane along
the axon and further studies are needed to answer this
question.
Nedd4-2 is not the only potential post-translational
regulator of Nav. An interaction between p11 (from the
S100 protein family) and Nav1.8 has been reported to
facilitate Nav1.8 sorting toward the cell membrane
(Okuse et al., 2002). Besides, ankyrin interacts with and
upregulates Nav1.5 in cardiac cells (Mohler et al., 2004)
as well as Nav1.2 and Nav1.6 at nodes of Ranvier
(Jenkins and Bennett, 2001; Garrido et al., 2003). In
addition, Navb-subunits fulﬁll important regulatory
functions. In particular, the b2-subunit was shown to
modulate mRNA and protein expression of various Nav
(Lopez-Santiago et al., 2006) and is increased after
nerve injury (Pertin et al., 2005). Finally, protein kinases
such as PKA or PKC also modulate VGSC, with PKA
increasing Nav1.8 and decreasing Nav1.7 currents
while PKC decreases Nav1.8 and Nav1.7 currents
(Vijayaragavan et al., 2004). Nedd4-2 interacts
speciﬁcally via one of its WW domains (protein–protein
interaction modules) with a PY motif situated in the
COOH termini of Nav or ENaC (Harvey et al., 1999;
Rougier et al., 2005). Previous studies have established
the connection between Nedd4-2 and the Nav in vitro
(Fotia et al., 2004; van Bemmelen et al., 2004;
Rougier et al., 2005). In cardiac cells, Nav1.5 can be
downregulated by Nedd4-2 (Abriel et al., 2000; van
Bemmelen et al., 2004) implying a probable modulation
of cardiac excitability. With the exception of Nav1.4 and
Nav1.9, all Nav contain the speciﬁc PY motif suggesting
an interaction with Nedd4-2. These include Nav1.6,
whose mRNA is the third most abundant among sodium
channels in the DRG (Berta et al., 2008); this channel
has recently been reported to be modulated by Nedd4-2
(Gasser et al., 2010). Additionally, Nav1.2, mainly
present in the central nervous system, has been shown
to be downregulated when associated with Nedd4-2
(Fotia et al., 2004; Rougier et al., 2005). In addition to
Nav, Voltage-gated K+ channels play major roles in
modulating electrical excitability in neurons. For
instance, KCNQ2/3/5contain a PY motif and is
subjected to Nedd4-2 dependent downregulation in a
Xenopus oocyte expression system (Ekberg et al.,
2007; Pongs, 2008; Bongiorno and Poronnik, 2011).
This regulation and modulation of K+ channels mightPlease cite this article in press as: Cachemaille M et al. Neuronal expression of
spared nerve injury model of neuropathic pain. Neuroscience (2012), http://dx.also be a key point in the excitability generated after a
peripheral nerve injury.
Finally, besides its expression level, Nedd4-2
is regulated by a direct phosphorylation as well
(Debonneville et al., 2001; Snyder, 2009). In particular,
serum- and glucocorticoid kinase 1 (Debonneville et al.,
2001) increases ENaC cell-surface expression through
a negative regulation of Nedd4-2 (Alvarez et al., 1999).
These ﬁndings imply a posttranslational regulation of
Nedd4-2 playing therefore a role in Nav modulation.
Upstream regulatory mechanisms of Nedd4-2 might
therefore represent other perspectives to explore in the
context of peripheral nerve injuries.CONCLUSION
In summary, we have demonstrated in vivo the presence
of the ubiquitin ligase Nedd4-2 in the rat DRG. Moreover
meticulous analyses of the immunoreactive cell
populations showed its presence mainly in small
nociceptive neurons, especially the non-peptidergic
neurons. We also colocalized Nedd4-2 with Nav1.7 and
Nav1.8. In a model of peripheral nerve injury, the
decrease of Nedd4-2-positive neurons suggests a
putative role in altered Nav turnover, especially Nav1.7,
which could contribute to hyperexcitability. Future
studies will shed light on the exact molecular impact of
Nedd4-2 on Nav in nociceptors and pathological pain.
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